Week In Review: BGI Genomics Plans $250 Million Shenzhen IPO
March 18, 2017 at 14:45 PM EDT
BGI Genomics, the contract sequencing and diagnostics divisions of China genomics sequencing company BGI, filed to IPO on the Shenzhen Chi-Next exchange with a proposed target of raising $250 million.
